
Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-...
INGELHEIM, Germany and AMSTERDAM, April 23, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and …